• Profile
Close

Delayed vs standard assessment for excision surgery in patients with Buruli ulcer in Benin: A randomised controlled trial

The Lancet Infectious Diseases Jun 04, 2018

Wadagni AC, et al. - Considering persistence of surgery as an adjunct therapy for Buruli ulcer disease following the introduction of streptomycin and rifampicin for 8 weeks as standard care, researchers examined the effect of delaying the decision to operate to 14 weeks on rates of healing without surgery. This randomised controlled trial of patients (aged 3 years or older) with confirmed disease demonstrated a beneficial effect of delaying the decision to operate. Antibiotics alone can led even large ulcers to heal, without delaying healing rate and without an increase in residual functional limitations.

Methods

  • Patients aged 3 years or older with confirmed disease were enrolled at one hospital in Lalo, Benin.
  • Random assignment of patients (1:1) to groups assessing the need for excision surgery 8 weeks (standard care) or 14 weeks after initiation of antimicrobial treatment was performed.
  • The number of patients healed without the need for surgery (not including skin grafting), was assessed as the primary endpoint in all patients in follow-up at 50 weeks (or last observation for those healed for >10 weeks).
  • The indications for surgery according to predefined criteria was checked by a doctor masked to treatment assignment.

Results

  • Researchers enrolled 119 patients from July 1, 2011, to Jan 15, 2015; two patients per group lost to follow-up.
  • They noted healed lesions in 55 (96%) of 57 participants in the delayed-decision group and 52 (90%) of 58 participants in the standard-care group at 1 year after start of antimicrobial treatment (relative risk [RR] 1·08, 95% CI 0·97–1·19).
  • The lesions healed without surgical intervention in 37 (67%) of 55 patients in the delayed-decision group, as did 25 (48%) of 52 in the standard-care group (RR 1·40, 95% CI 1·00–1·96).
  • The two groups did not differ regarding the time to heal and residual functional limitations (median time to heal 21 weeks [IQR 10–27] in the delayed-decision group and 21 weeks [10–39] in the standard-care group; functional limitations in six [11%] of 57 and three [5%] of 58 patients; p=0·32).
  • Reduced median duration of hospitalisation (5 days [IQR 0–187] vs 131 days [0–224]; p=0·024) and wound care (153 days [IQR 56–224] vs 182 days [94–307]; p=0·036) were evident with postponing the decision to operate.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay